Skip to main content
OpenTrials

Clinical trial condition

Castration-resistant Prostate Cancer

Explore clinical trials studying Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

64 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Castration-resistant Prostate Cancer trial results

Completed

Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer

NCT02025010

Conditions
Castration-resistant Prostate Cancer
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Commack Commack, New York, United States
View Trial Details
Completed

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

NCT02380274

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Site USSUB1007 Homewood, Alabama, United States
  • Site USSUB1010 Anchorage, Alaska, United States
  • Site USSUB1111 Phoenix, Arizona, United States
  • Site US1104 Scottsdale, Arizona, United States
View all 148 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details
Completed

ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer

NCT04028388

Conditions
Castration-resistant Prostate Cancer, Prostate Cancer Metastatic
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • Providence Cancer Institute Portland, Oregon, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View all 28 locations
View Trial Details
Completed

COMbination of Bipolar Androgen Therapy and Nivolumab

NCT03554317

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Safety and Pharmacokinetics of ODM-209

NCT03878823

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Rigshospitalet, University Hospital of Copenhagen Copenhagen, Denmark
  • Helsinki University Central Hospital Helsinki, Finland
  • Tampere University Hospital Tampere, Finland
  • Institut Gustave Roussy Villejuif, France
View Trial Details

Related conditions